The Food and Drug Administration on Thursday approved Bristol Myers Squibb’s Camzyos, the first drug to treat the cause of an inherited form of heart failure known as obstructive hypertrophic cardiomyopathy.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,